Clinical Trial Update: Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

View source ↗

Summary

A recruiting clinical trial is evaluating the immunogenicity, efficacy and safety of a recombinant herpes zoster vaccine in frail, immunocompromised patients. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Immunocompromised Patients | Status: RECRUITING